Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 25, Issue 34, Pages 5097-5104
Publisher
Baishideng Publishing Group Inc.
Online
2019-09-12
DOI
10.3748/wjg.v25.i34.5097
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan
- (2019) Mitsushige Sugimoto et al. Frontiers in Pharmacology
- A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial
- (2019) Wei-Chen Tai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High‐dose PPI‐amoxicillin dual therapy with or without bismuth for first‐line Helicobacter pylori therapy: A randomized trial
- (2019) Lou Yu et al. HELICOBACTER
- Vonoprazan and Helicobacter pylori Treatment: A Lesson From Japan or a Limited Geographic Phenomenon?
- (2019) Amin Talebi Bezmin Abadi et al. Frontiers in Pharmacology
- Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori
- (2018) Min Li et al. HELICOBACTER
- Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication
- (2018) Chonticha Auesomwang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis
- (2018) Giuseppe Losurdo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- New fecal test for non-invasive Helicobacter pylori detection: A diagnostic accuracy study
- (2018) Andrea Iannone et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker
- (2018) Hideki Mori et al. Journal of Neurogastroenterology and Motility
- Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori : A multicenter, prospective, randomized trial
- (2017) Soichiro Sue et al. HELICOBACTER
- Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies
- (2017) Javier P. Gisbert et al. HELICOBACTER
- Significance of dormant forms of Helicobacter pylori in ulcerogenesis
- (2017) Vasiliy Ivanovich Reshetnyak et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?
- (2017) Enzo Ierardi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Optimized high-dose amoxicillin–proton-pump inhibitor dual therapies fail to achieve high cure rates in China
- (2017) Dian-Chun Fang et al. Saudi Journal of Gastroenterology
- Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-LineHelicobacter pyloriEradication: A Randomized Controlled Trial
- (2017) Masafumi Maruyama et al. Canadian Journal of Gastroenterology and Hepatology
- Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy forHelicobacter pylorieradication: a phase III, randomised, double-blind study
- (2016) Kazunari Murakami et al. GUT
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
- (2016) P Malfertheiner et al. GUT
- Efficacy and safety of high-dose dual therapy forHelicobacter pylorirescue therapy: A systematic review and meta-analysis
- (2016) Cai Ping Gao et al. Journal of Digestive Diseases
- http://www.jgld.ro/wp/archive/y2016/n2/a4/
- (2016) Journal of Gastrointestinal and Liver Diseases
- Helicobacter pyloriDNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis
- (2016) Floriana Giorgio et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Vaccine againstHelicobacter pylori: Inevitable approach
- (2016) Amin Talebi Bezmin Abadi WORLD JOURNAL OF GASTROENTEROLOGY
- Helicobacter pylori and gastric acid: an intimate and reciprocal relationship
- (2016) Helge L. Waldum et al. Therapeutic Advances in Gastroenterology
- CYP2C19 polymorphism influencesHelicobacter pylorieradication
- (2016) Chao-Hung Kuo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The binding selectivity of vonoprazan (TAK-438) to the gastric H+,K+-ATPase
- (2015) D. R. Scott et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects
- (2015) H. Jenkins et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Optimised empiric triple and concomitant therapy forHelicobacter pylorieradication in clinical practice: the OPTRICON study
- (2015) J. Molina-Infante et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
- (2015) K. Ashida et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015
- (2015) Rocco Maurizio Zagari et al. DIGESTIVE AND LIVER DISEASE
- High-Dose Extended-Release Lansoprazole (Dexlansoprazole) and Amoxicillin Dual Therapy forHelicobacter pyloriInfections
- (2014) Taraq A. Attumi et al. HELICOBACTER
- Helicobacter pyloriand Nonmalignant Diseases
- (2014) Enzo Ierardi et al. HELICOBACTER
- Culture-guided treatment approach forHelicobacter pyloriinfection: Review of the literature
- (2014) Giovanni Cammarota WORLD JOURNAL OF GASTROENTEROLOGY
- Overview of the phytomedicine approaches againstHelicobacter pylori
- (2014) Filipa F Vale WORLD JOURNAL OF GASTROENTEROLOGY
- Influence of pretreatment with H2 receptor antagonists on the cure rates of Helicobacter pylori eradication
- (2013) Chikako Tokoro et al. MEDICAL SCIENCE MONITOR
- Effects of CYP2C19 Loss-of-Function Variants on the Eradication of H. pylori Infection in Patients Treated with Proton Pump Inhibitor-Based Triple Therapy Regimens: A Meta-Analysis of Randomized Clinical Trials
- (2013) Hui-Lin Tang et al. PLoS One
- How antibiotic resistances could changeHelicobacter pyloritreatment: A matter of geography?
- (2013) Enzo Ierardi WORLD JOURNAL OF GASTROENTEROLOGY
- Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection
- (2012) A. G. McNicholl et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Reply to Letter to the Editor: Posterior Malleolar Stabilization of Syndesmotic Injuries is Equivalent to Screw Fixation
- (2010) Anna N. Miller et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Does Pretreatment with Lansoprazole Influence Helicobacter pylori Eradication Rate and Quality of Life?
- (2010) Masafumi Inoue et al. DIGESTION
- Helicobacter pylori treatment in the era of increasing antibiotic resistance
- (2010) D. Y. Graham et al. GUT
- Helicobacter pylori antibiotic resistance and [13C]urea breath test values
- (2010) V. De Francesco et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Meta-analysis: High-dose proton pump inhibitors versus standard dose in triple therapy forHelicobacter pylorieradication.
- (2008) A. VILLORIA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- New concepts of resistance in the treatment of Helicobacter pylori infections
- (2008) David Y Graham et al. Nature clinical practice. Gastroenterology & hepatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now